Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort

Eitemau Tebyg

• Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort
  gan: Lammi, Matthew R., et al.
  Cyhoeddwyd: (2017)
• Association between Initial Oral Therapy and Outcomes in Systemic Sclerosis-related Pulmonary Arterial Hypertension: Observations from PHAROS
  gan: Lammi, Matthew R., et al.
  Cyhoeddwyd: (2016)
• Letter to the Editor re: Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension
  gan: Saketkoo, Lesley Ann, et al.
  Cyhoeddwyd: (2017)
• Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS)
  gan: Kolstad, Kathleen D., et al.
  Cyhoeddwyd: (2018)
• Survival in Systemic Sclerosis-Pulmonary Arterial Hypertension by Serum Autoantibody Status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry
  gan: Hinchcliff, Monique, et al.
  Cyhoeddwyd: (2015)